About the article “Factors associated with anthracycline-induced cardiotoxicity in breast cancer patients”

Authors

Downloads

Download data is not yet available.

References

1. Vicente-Hernández B, Sarre-Álvarez D, Rodríguez-Weber FL, Díaz-Greene EJ. Cardiotoxicidad por antracíclicos. Med Int Méx [internet] 2015 [citado 4 Abril 2020]; 31:567-577. Disponible en: https://www.medigraphic.com/pdfs/medintmex/mim-2015/mim155j.pdf&sa=U&ved=2ahUKEwjltqSf69boAhUHTt8KHTPwBZYQFjABegQIBBAB&usg=AOvVaw1EKIbtVRbuWluzUa4UuM0o

2. Romero-Barzola MY, Sierra-Santos L. Tratamiento con antraciclinas, un antecedente sospechoso. Rev Clín Med Fam [internet] 2018 [citado 4 Abril 2020]; 11(1): 28-30. Disponible en: http://scielo.isciii.es/pdf/albacete/v11n1/1699-695X-albacete-11-01-28.pdf&sa=U&ved=2ahUKEwim7buS7NboAhXIdN8KHevEB9wQFjABegQIBxAB&usg=AOvVaw2-PJjBNb3TAbWKMOlNi3Ev

3. Pedraza-Rodríguez EM, González-Velázquez VE, Rodríguez-Rodríguez LL. Factores asociados a la cardiotoxicidad inducida por antraciclinas en pacientes con cáncer de mama. Univ Méd Pinareña [Internet]. 2020 [citado 30 Marzo 2020]; 16(1): e383. Disponible en: http://www.revgaleno.sld.cu/index.php/ump/article/view/383

4. Flórez J, Armijo JA, Mediavilla A. Farmacología humana. [internet]. 6ta Edición. España: Elsevier. [actualizado: 2014; citado: 4 Abril 2020]. Disponible en: https://www.edicionesjournal.com/Papel/9788445823163/Farmacolog%25C3%25ADa%2BHumana%2B-%2B6%25C2%25BA%2BEd&sa=U&ved=2ahUKEwjs0Kj86-NLoAhWmmOAKHddlC8kQFjAAegQIChAB&usg=AovVaw1U2IZbVTRyeUBOeUp7tpeg

5. Navarrete-Rodríguez EM, Zapata-Tarrés MM, Vera-Hermosillo H, Erdmenger-Orellana J, López-Martínez B, Becerra-Becerra R. Diagnóstico oportuno del daño al miocardio en pacientes tratados con antraciclinas: un reto para el siglo XXI. Bol Med Hosp Infant Mex [internet] 2015 [citado 4 Abril 2020]; 70(2): 72-77. Disponible en: https://www.scielo.org.mx/pdf/bmim/v70n2/v70n2a2.pdf

6. Volkova M, Russell R. Anthracycline cardiotoxicity: prevalence, pathogenesis and treatment. Curr Cardiol Rev [internet] 2018 [citado 4 Abril 2020]; (7):214-220. Disponible en: https://www.ncbi.nlm.nih.gov/m/pubmed/22758622&sa=U&ved=2ahUKEwiKpq3r7dboAhWsmeAKHb_xBYQQFjALegQIAxAB&usg=AOvVaw38HUCBq2BaKWfUsoiPpOEc

Downloads

Published

2020-04-30

How to Cite

1.
Rodríguez-Venegas E de la C, Hernández-García OL. About the article “Factors associated with anthracycline-induced cardiotoxicity in breast cancer patients”. Univ. Méd. Pinareña [Internet]. 2020 Apr. 30 [cited 2025 Apr. 13];17(3):e487. Available from: https://revgaleno.sld.cu/index.php/ump/article/view/487

Issue

Vol. 17 No. 3 (2021): September-December

Section

Letter to the Editor

License

Authors who have published with this journal accept the following terms: authors will retain their copyright and guarantee the journal the right of first publication of their work, which will be simultaneously subject to the Creative Commons recognition license that allows third parties to share the work as long as its author is indicated and its first publication is this journal. Authors may adopt other non-exclusive license agreements for the distribution of the version of the published article (e.g., deposit it in an institutional telematic archive or publish it in a monographic volume) provided that the initial publication in this journal is indicated. Authors are permitted and encouraged to disseminate their article using Internet (e.g., in institutional telematic archives or on their website) before and during the submission process, which may lead to interesting exchanges and increased citations of the published work. (See The Effect of Open Access).

Most read articles by the same author(s)